Literature DB >> 15483265

Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation.

Chan-Lan Kim1, Ayako Karino1, Naotaka Ishiguro1, Morikazu Shinagawa1, Motoyoshi Sato2, Motohiro Horiuchi1.   

Abstract

The C-terminal portion of the prion protein (PrP), corresponding to a protease-resistant core fragment of the abnormal isoform of the prion protein (PrP(Sc)), is essential for prion propagation. Antibodies to the C-terminal portion of PrP are known to inhibit PrP(Sc) accumulation in cells persistently infected with prions. Here it was shown that, in addition to monoclonal antibodies (mAbs) to the C-terminal portion of PrP, a mAb recognizing the octapeptide repeat region in the N-terminal part of PrP that is dispensable for PrP(Sc) formation reduced PrP(Sc) accumulation in cells persistently infected with prions. The 50% effective dose was as low as approximately 1 nM, and, regardless of their epitope specificity, the inhibitory mAbs shared the ability to bind cellular prion protein (PrP(C)) expressed on the cell surface. Flow cytometric analysis revealed that mAbs that bound to the cell surface during cell culture were not internalized even after their withdrawal from the growth medium. Retention of the mAb-PrP(C) complex on the cell surface was also confirmed by the fact that internalization was enhanced by treatment of cells with dextran sulfate. These results suggested that anti-PrP mAb antagonizes PrP(Sc) formation by interfering with the regular PrP(C) degradation pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483265     DOI: 10.1099/vir.0.80113-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

Review 1.  Prion propagation: the role of protein dynamics.

Authors:  John A Pezza; Tricia R Serio
Journal:  Prion       Date:  2007-01-10       Impact factor: 3.931

2.  Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Authors:  Joanna Pankiewicz; Frances Prelli; Man-Sun Sy; Richard J Kascsak; Regina B Kascsak; Daryl S Spinner; Richard I Carp; Harry C Meeker; Marcin Sadowski; Thomas Wisniewski
Journal:  Eur J Neurosci       Date:  2006-05       Impact factor: 3.386

3.  Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.

Authors:  Morikazu Imamura; Nobuko Kato; Miyako Yoshioka; Hiroyuki Okada; Yoshifumi Iwamaru; Yoshihisa Shimizu; Shirou Mohri; Takashi Yokoyama; Yuichi Murayama
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  The crystal structure of an octapeptide repeat of the prion protein in complex with a Fab fragment of the POM2 antibody.

Authors:  Mridula Swayampakula; Pravas Kumar Baral; Adriano Aguzzi; Nat N V Kav; Michael N G James
Journal:  Protein Sci       Date:  2013-05-31       Impact factor: 6.725

5.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

6.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.

Authors:  Zhifu Shan; Takeshi Yamasaki; Akio Suzuki; Rie Hasebe; Motohiro Horiuchi
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

8.  Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.

Authors:  David R Taylor; Edward T Parkin; Sarah L Cocklin; James R Ault; Alison E Ashcroft; Anthony J Turner; Nigel M Hooper
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

9.  Generation of genetic engineering monoclonal antibodies against prion protein.

Authors:  Yin-Xia Huang; Jun Han; Chen-Fang Dong; Li Sun; Chen Gao; Xiao-Fan Wang; Lu Han; Wei Zhou; Bao-Yun Zhang; Hui-Ying Jiang; Mi-Fang Liang; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2007-05-08       Impact factor: 3.402

10.  Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.

Authors:  Gregory J Raymond; Brent Race; Jason R Hollister; Danielle K Offerdahl; Roger A Moore; Ravindra Kodali; Lynne D Raymond; Andrew G Hughson; Rebecca Rosenke; Dan Long; David W Dorward; Gerald S Baron
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.